1st May 2008 15:04
GlaxoSmithKline PLC01 May 2008 Total Voting Rights and Capital In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc("the Company") hereby notifies the market of the following: The Company's issued share capital as at 30 April 2008 consisted of5,866,590,834 Ordinary shares of 25p each with voting rights, of which484,194,158 Ordinary shares are held in Treasury. Therefore, the total number of voting rights in the Company is 5,382,396,676.This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to their interest in, the Company under the Financial ServicesAuthority's Disclosure and Transparency Rules. S M BicknellCompany Secretary 1 May 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline